News Release

Nucleoside analogs for messenger RNA metabolic labelling and sequencing

Peer-Reviewed Publication

KeAi Communications Co., Ltd.

STUDY OF THE CHANGES OF GENE EXPRESSION PROFILES USING RNA NUCLEOSIDE LABELLING AND CHEMICAL SEQUENCING

image: STUDY OF THE CHANGES OF GENE EXPRESSION PROFILES USING RNA NUCLEOSIDE LABELLING AND CHEMICAL SEQUENCING view more 

Credit: Xiao Shu, Chenyang Huang, Tengwei Li, Jie Cao, Jianzhao Liu

High-throughput RNA-sequencing (RNA-seq) is widely used to profile global cellular gene expression and gain insights into cellular biological processes; however, effectively tracking dynamic changes in cellular mRNA expression remains a challenge. Being able to do so can help researchers to investigate transcripts over a time frame.

In a study published in the KeAi journal Fundamental Research, a team of researchers from China has pioneered a novel method. It incorporated an adenosine analog, N6-allyladenosine (a6A) into newly transcribed RNAs by nucleoside salvage pathways. Following the metabolic labelling, the researchers employed a chemical iodination treatment to convert a6A within the transcripts into a distinct variant structure. This modified structure can then be accurately identified as base mutation sites using high-throughput sequencing technology.

“We believe that an increasing number of nucleoside analogs will be explored for uses as chemical sequencing tags with the hope of achieving specific labelling on different kinds of RNA, especially mRNA,” says Jianzhao Liu, corresponding author of the study, and a professor at the Institute of Biological Macromolecules at Department of Polymer Science and Engineering of Zhejiang University.

The team found that a6A can be recognized by RNA polymerase and incorporated into the newly synthesized cellular mRNA. Meanwhile, the allyl group on a6A is bio-orthogonally treated with iodine and a6A is converted into a structure of 1,N6-cyclized adenosine. Consequently, this modification induces base mismatch during RNA reverse transcription, leading to the generation of A- to C/T mutation reads in subsequent RNA-seq analysis.

At present, an antibody suitable for the immunoprecipitation of a6A-containing RNA is commercially available. Leveraging these resources, the researchers used a6A in their investigation of alterations in cellular gene expression profiles under methionine-free conditions. Furthermore, they utilized a6A-IP as a validation tool to confirm the findings obtained through sequencing. This integrated approach allowed for comprehensive and reliable analysis of gene expression dynamics (see image).

“Our technique will enable researchers to track the newly formed a6A-containing transcripts and investigate the dynamics of these transcripts, including RNA synthesis and decay,” says Liu. “a6A provides not only a chemical tag for sequencing, but also a tag for antibody enrichment.”

###

Contact the author: Jianzhao Liu, Department of Polymer Science and Engineering, Zhejiang University, Zheda Road 38, Hangzhou 310027, China, liujz@zju.edu.cn

The publisher KeAi was established by Elsevier and China Science Publishing & Media Ltd to unfold quality research globally. In 2013, our focus shifted to open access publishing. We now proudly publish more than 100 world-class, open access, English language journals, spanning all scientific disciplines. Many of these are titles we publish in partnership with prestigious societies and academic institutions, such as the National Natural Science Foundation of China (NSFC).

 


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.